CVKD
Price
$13.09
Change
+$1.64 (+14.32%)
Updated
Dec 18, 04:55 PM (EDT)
VINC
Price
$0.20
Change
+$0.01 (+5.26%)
Updated
Dec 18, 04:59 PM (EDT)
104 days until earnings call
Ad is loading...

CVKD vs VINC

Header iconCVKD vs VINC Comparison
Open Charts CVKD vs VINCBanner chart's image
Cadrenal Therapeutics
Price$13.09
Change+$1.64 (+14.32%)
Volume$300
CapitalizationN/A
Vincerx Pharma
Price$0.20
Change+$0.01 (+5.26%)
Volume$24.06K
CapitalizationN/A
CVKD vs VINC Comparison Chart
Loading...
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VINC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVKD vs. VINC commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVKD is a Hold and VINC is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CVKD: $11.45 vs. VINC: $0.19)
Brand notoriety: CVKD and VINC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVKD: 66% vs. VINC: 78%
Market capitalization -- CVKD: $18.99M vs. VINC: $6.46M
CVKD [@Biotechnology] is valued at $18.99M. VINC’s [@Biotechnology] market capitalization is $6.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVKD’s FA Score shows that 0 FA rating(s) are green whileVINC’s FA Score has 1 green FA rating(s).

  • CVKD’s FA Score: 0 green, 5 red.
  • VINC’s FA Score: 1 green, 4 red.
According to our system of comparison, VINC is a better buy in the long-term than CVKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVKD’s TA Score shows that 3 TA indicator(s) are bullish while VINC’s TA Score has 5 bullish TA indicator(s).

  • CVKD’s TA Score: 3 bullish, 6 bearish.
  • VINC’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, VINC is a better buy in the short-term than CVKD.

Price Growth

CVKD (@Biotechnology) experienced а -9.41% price change this week, while VINC (@Biotechnology) price change was -10.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

CVKD is expected to report earnings on Nov 07, 2024.

VINC is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVKD($19M) has a higher market cap than VINC($6.46M). CVKD YTD gains are higher at: 3.167 vs. VINC (-83.729). CVKD has higher annual earnings (EBITDA): -7.61M vs. VINC (-27.1M). VINC has more cash in the bank: 10.1M vs. CVKD (4.36M). CVKD has less debt than VINC: CVKD (2.23K) vs VINC (1.64M). CVKD (0) and VINC (0) have equivalent revenues.
CVKDVINCCVKD / VINC
Capitalization19M6.46M294%
EBITDA-7.61M-27.1M28%
Gain YTD3.167-83.729-4%
P/E RatioN/AN/A-
Revenue00-
Total Cash4.36M10.1M43%
Total Debt2.23K1.64M0%
TECHNICAL ANALYSIS
Technical Analysis
CVKDVINC
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 20 days ago
86%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VINC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX56.303.32
+6.27%
MoonLake Immunotherapeutics
ILMN143.12-1.28
-0.89%
Illumina
CNVS3.45-0.05
-1.43%
Cineverse Corp
SLI1.42-0.03
-2.07%
Standard Lithium Ltd
AVNS17.02-0.73
-4.11%
Avanos Medical

CVKD and

Correlation & Price change

A.I.dvisor tells us that CVKD and REVB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and REVB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
+4.09%
REVB - CVKD
29%
Poorly correlated
-3.33%
GDTC - CVKD
29%
Poorly correlated
-3.02%
RNXT - CVKD
23%
Poorly correlated
N/A
VINC - CVKD
23%
Poorly correlated
-0.31%
GOSS - CVKD
22%
Poorly correlated
+1.71%
More

VINC and

Correlation & Price change

A.I.dvisor indicates that over the last year, VINC has been loosely correlated with INKT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if VINC jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VINC
1D Price
Change %
VINC100%
-0.31%
INKT - VINC
39%
Loosely correlated
-7.12%
APVO - VINC
33%
Loosely correlated
+8.25%
RNA - VINC
31%
Poorly correlated
-1.95%
VNDA - VINC
30%
Poorly correlated
+2.16%
IOVA - VINC
30%
Poorly correlated
-0.38%
More